Systemic Mastocytosis with Associated Hematologic Neoplasm

• FDA approval · 2018-06-21
  FDA Approved: RYDAPT — Supplemental Application (Novartis Pharmaceuticals Corporation)

  FDA approves a supplemental application for RYDAPT (midostaurin) from Novartis Pharmaceuticals; the update expands or modifies the drug’s la…